0001144204-11-020631.txt : 20110407
0001144204-11-020631.hdr.sgml : 20110407
20110407095855
ACCESSION NUMBER: 0001144204-11-020631
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20110406
FILED AS OF DATE: 20110407
DATE AS OF CHANGE: 20110407
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GENEREX BIOTECHNOLOGY CORP
CENTRAL INDEX KEY: 0001059784
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 820490211
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0731
BUSINESS ADDRESS:
STREET 1: 33 HARBOUR SQ
STREET 2: STE 202
CITY: TORONTO ONTARIO CANADA
STATE: A1
ZIP: M5J 2G2
BUSINESS PHONE: 4163642551
MAIL ADDRESS:
STREET 1: 33 HARBOUR SQ
STREET 2: STE 202
CITY: TORONTO ONTARIO CA
STATE: A1
ZIP: M5J 2G2
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: FLETCHER MARK
CENTRAL INDEX KEY: 0001229529
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-25169
FILM NUMBER: 11744847
MAIL ADDRESS:
STREET 1: 33 HARBOUR SQUARE
CITY: TORONTO ONTARIO CANADA
STATE: A1
ZIP: M5J2G2
4
1
v217837_ex.xml
X0303
4
2011-04-06
0
0001059784
GENEREX BIOTECHNOLOGY CORP
GNBT
0001229529
FLETCHER MARK
33 HARBOUR SQUARE
SUITE 102
TORONTO ONTARIO CANADA
A1
M5J2G2
BRITISH COLUMBIA, CANADA
0
1
0
0
See Remarks
Common Stock
2011-04-06
4
P
0
20000
0.239
A
286077
D
President, CEO, General Counsel and Secretary
/s/ Mark Fletcher
2011-04-06